THOMAS CHRISTOPHER SMITH

Allopathic & Osteopathic Physicians|Family Medicine AUGUSTA, GA NPI 1013303262

General Payments — all program years on this page

$1,739.80

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 85
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $347.59 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $347.5919

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $192.585
2019 $492.8619
2020 $160.8010
2021 $280.9216
2022 $211.7413
2023 $53.313
2024 $347.5919

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086152603 Bayer Healthcare Pharmaceuticals Inc. $14.55 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096992708 Novo Nordisk Inc $16.85 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097632502 Novo Nordisk Inc $15.64 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104326562 AstraZeneca Pharmaceuticals LP $15.93 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104478718 AstraZeneca Pharmaceuticals LP $16.16 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105600259 AstraZeneca Pharmaceuticals LP $16.77 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105704896 AstraZeneca Pharmaceuticals LP $18.61 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105772102 AstraZeneca Pharmaceuticals LP $25.11 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106128028 ABBVIE INC. $15.23 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114437503 Exact Sciences Corporation $18.61 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116282197 GlaxoSmithKline, LLC. $13.41 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116335755 GlaxoSmithKline, LLC. $15.23 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117687322 Amgen Inc. $16.34 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118985754 Otsuka America Pharmaceutical, Inc. $25.58 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118985756 Otsuka America Pharmaceutical, Inc. $28.27 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118985758 Otsuka America Pharmaceutical, Inc. $23.00 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132076402 PFIZER INC. $14.86 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141653941 Merck Sharp & Dohme LLC $20.27 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141653953 Merck Sharp & Dohme LLC $17.17 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.